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ABSTRACT
Mannose-binding lectin (MBL) plays an important role in the innate immune response. Three alleles in
the MBL gene, and one allele of the promoter, independently cause low serum MBL levels as compared
with the wild-type. This study investigated the relationship between MBL genotype and the occurrence
of nosocomial infection among neonates in a neonatal intensive care unit (NICU). Prospectively
gathered information concerning nosocomial infection was available for 742 neonates from a recently
performed surveillance study in an NICU. DNA was isolated from Guthriecards for a subgroup of 204
neonates who stayed in the NICU for ‡4 days. After a pre-PCR for the MBL gene in blood spots on
Guthriecards, mutations were analysed by real-time PCR to detect six mutations in the MBL gene. An
MBL genotype could be determined for 186 neonates. As compared to term neonates, genotypes
encoding MBL-deficient haplotypes were significantly more prevalent among pre-term neonates. Forty-
one of these neonates developed sepsis, with blood cultures yielding coagulase-negative staphylococci
in 25 cases. Pneumonia occurred in 30 cases, with various causative organisms. No relationship was
found between MBL genotype and the risk of nosocomial sepsis or pneumonia, even after correction for
birth-weight, perhaps because of an insufficient correlation between genotype and the concentration of
functional MBL. In addition, most bloodstream infections in the NICU were caused by coagulase-
negative staphylococci, to which MBL binds poorly.
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INTRODUCTION
The immune response consists of two separate
systems. The first system comprises the aspecific
innate immune system, which includes the com-
plement system and mannose-binding lectin
(MBL). The second system is the more specific
adaptive immune system, which includes the
range of white blood cells. The latter system is
more effective, but is time-delayed. If the adaptive
immune system is not compromised, the innate
immune system is of minor importance [1].
However, if the adaptive immune system is
compromised, the influence of any MBL defi-
ciency becomes apparent [2,3].
MBL is a Ca2+-dependent collagenous lectin,
and has a bouquet-like structure that recognises
and can bind to repeating pattern structures of
polysaccharides on the surfaces of many micro-
organisms. MBL functions as an ante-antibody,
which means that it opsonises microorganisms
before specific IgM can be produced [4]. Subse-
quently, an MBL-associated serine protease
(MASP-2), which is functionally analogous to
C1-esterase, activates the complement cascade
that leads to killing of the microorganisms [5].
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The MBL monomer is encoded by the MBL-2
gene on human chromosome 10, and functional
MBL consists of a polymer of several MBL
monomers. Three single base-pair substitutions
in exon-1 of the MBL-2 gene give rise to three
mutant alleles (B, C and D), leading to failure of
assembly of the functional MBL multimer. These
polymorphisms occur in about one-third of the
human population, with the frequency of occur-
rence of different polymorphisms being related to
various ethnic groups [6]. The heterozygous
polymorphisms reduce the amount of functional
MBL by five- to ten-fold, whereas the homozy-
gous mutations lead to almost undetectable titres
of MBL [5]. Furthermore, several base-pair sub-
stitutions in the promoter region of the MBL-2
gene have been described, leading to several
promoter variants, some of which decrease the
functional MBL serum level significantly [6].
The incidence of nosocomial infection in neona-
tal intensive care units (NICUs) is high [7]. The
most important risk-factor in this patient category
is low birth-weight [8,9], which is a risk-factor that,
in part, reflects the more invasive treatment, e.g.,
with intravascular catheters and mechanical ven-
tilation, of these infants. Furthermore, the adaptive
host response to infection in neonates, especially
pre-term neonates, is impaired for several reasons
[10–15]. MBL deficiency may therefore be a risk-
factor for infection in this patient category. In
addition, an association between polymorphisms
in the MBL-2 gene and pre-term birth has been
reported [16]. Accordingly, the present study
investigated the influence of MBL genotype
on the risk of nosocomial infection by determining
the MBL-2 genotype of 204 neonates.
MATERIALS AND METHODS
Surveillance study
During 1998–2000, a prospective study was performed to
investigate nosocomial bloodstream infection and pneumonia
in 742 neonates admitted to the Neonatal Intensive Care Unit
of the VU University Medical Centre. Local infection defini-
tions were used, based on clinical and microbiological data
[17], that were adapted from CDC infection definitions for
children aged <1 year [18]. Several potential baseline risk-
factors for nosocomial bloodstream infection and pneumonia
were recorded. Neonates who stayed for >4 days in the NICU
were eligible for inclusion in the study of MBL genotypes.
The present study investigated retrospectively whether the
MBL genotype could have been a risk-factor for nosocomial
infection in the original surveillance study.
Investigation of single nucleotide polymorphisms (SNPs) in
neonatal DNA
In The Netherlands, a blood sample is collected by heel
puncture on to a Guthriecard from neonates during the first
week after birth. These samples are investigated at the
National Institute of Public Health and the Environment
(Bilthoven, The Netherlands) for certain congenital diseases,
and are then stored for 5 years. Parents of eligible neonates
were asked for permission (informed consent) to use the
Guthriecard of their child for DNA isolation and MBL gene
analysis [19]. The study was approved by the local Ethical
Committee.
Isolation of DNA. In brief, blood was eluted from Guthriecards
by soaking three disks from each card in Tris-EDTA buffer
(10 mM Tris-HCl, pH 8.3, 1 mM EDTA) and then incubating
for 10 min at 56C. The samples were then centrifuged at
16 100 g for 10 min. DNA was isolated from the resulting
supernatant using a QIAamp kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions, and was eluted
in 100 lL of the elution buffer contained in the kit. DNA
samples were frozen at )20C until use.
PCR. A nested PCR approach was used because the amount
of DNA obtained from the Guthriecards was too small for
direct detection of SNPs. A pre-PCR with two primers
flanking the MBL-2 gene was performed to amplify a DNA
segment containing all six SNP targets. SNP analysis was
then performed using six different real-time TaqMan assays
[19]. Each assay consisted of non-labelled forward and
reverse primers in combination with two fluorescent TaqMan
oligonucleotide probes, labelled differently for wild-type and
mutations. Because of the close proximity of the mutations
in exon-1, these were enclosed by one primer pair.
Oligonucleotides corresponding to wild-type promoter
variants L, Y and P, and the wild-type structural gene A,
were labelled with the fluorescent VIC molecule.
Oligonuclotides corresponding to mutation promoter
variants H, X, Q and the mutation haplotypes of the
structural gene B, C and D were labelled with
6-carboxy-fluorescein (FAM). Endpoint detection was
performed on an ABI Prism 7000 (Applied Biosystems,
Warrington, UK), and the results were analysed using
sequence detection software v.1.01 (Applied Biosystems).
In theory, there are 26 = 64 possible combinations for six
SNPs, but because of a strong linkage dis-equilibrium between
promotor and exon, there are only seven well-known haplo-
types: four promoter variants with a wild-type structural gene
(HYPA, LYPA, LYQA and LXPA) and three haplotypes with a
mutant structural gene (LYPB, HYPD and LYQC) [20]. Every
individual expresses two MBL haplotypes.
Analysis of the effect of MBL genotype on risk of nosocomial
infection
Genotypes were stratified in six combined promotor–exon
groups (YA ⁄YA, YA ⁄XA, XA ⁄XA, YA ⁄O, XA ⁄O and O ⁄O) and
in three exon groups (A ⁄A, A ⁄O and O ⁄O) [21,22]. The risk of
infection was investigated for (i) bloodstream infection (BSI),
(ii) pneumonia and (iii) BSI or pneumonia or both. Analysis
was performed using multiple logistic regression with the
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potential risk-factors for nosocomial infection that had been
evaluated in the previous surveillance study in the NICU of
the VU University Medical Centre [17]. These factors were
birth-weight category (<1000 g, 1000–1499 g, 1500–2499 g,
‡2500 g), gender, place of birth (VU University Medical Centre
or elsewhere), type of birth (Caesarian section or vaginal),
presence of meconium-stained amniotic fluid, premature
rupture of membranes (>24 h before delivery) and multiple
birth. Statistical analysis was performed using SPSS v.12.0
(SPSS Inc., Chicago, IL, USA).
Genotype distribution, according to Garred et al. [21] and
Neth et al. [22], was compared for pre-term neonates and term
neonates. Further analysis investigated whether significant
differences existed between early (gestational age <32 weeks)
and late (gestational age 32–36 weeks) pre-term neonates.
RESULTS
Parents of 512 neonates were asked to give
informed consent for participation in this study.
Ultimately, 204 Guthriecards were investigated,
with 188 cases yielding sufficient DNA after pre-
PCR for further analysis. In general, the results
for estimation of SNPs were good; however, no
result was obtained in 11 of the 6 · 188 = 1128
SNP estimations, although the MBL genotype
could still be deduced in most cases. In one of
the 188 DNA specimens, the combinations of
SNPs could not be translated into known hap-
lotypes according to Garred et al. [21] and Neth
et al. [22]. This specimen had the combination
L ⁄H–Y ⁄X–P ⁄P–A ⁄A–no result–A ⁄A. There was
another specimen for which each single SNP was
estimated, but which could not be allocated to
one of the seven well-known haplotypes. Thus,
186 MBL genotypes were investigated in relation
to infection risk; 35 (19%) of 186 neonates had
two low-level MBL haplotypes (LXPA, LYPB,
HYPD or LYQC), and 69 (37%) had one low-
level haplotype.
Results of bacterial cultures were retrieved
from the previous study [17] and are shown in
Table 1. Coagulase-negative staphylococci
(CoNS) were the most frequent cause of BSI.
There was no predominant causative microor-
ganism for pneumonia. In total, 41 neonates had
BSI, and 30 had pneumonia; eight neonates had
BSI as well as pneumonia. The MBL genotypes for
infected and non-infected neonates are shown in
Table 2. In a univariate analysis, as well as in a
multiple analysis with other baseline risk-factors
for nosocomial infection, no relationship was
found between the MBL genotype of the neonates
and the risk of infection. Birth-weight was the
only significant risk-factor for nosocomial
infection (Table 3).
No significant differences were revealed
between individual low and medium MBL
genotypes among term and pre-term neonates.
However, the wild-type genotype was signifi-
cantly more prevalent among term neonates; thus
mutant genotypes, overall, occurred significantly
more frequently among the pre-term neonates.
No differences were detected between early and
late pre-term neonates.
DISCUSSION
MBL is present in the serum of pre-term neonates
and in amniotic fluid, and the amount of MBL
Table 1. Causative organisms of infection
Causative organism n
Bloodstream
infection
Coagulase-negative staphylococci 25
Bacillus cereus 3
Staphylococcus aureus 3
Viridans group streptococci 1
Enterobacter cloacae 1
No organism isolated 8
Total 41
Pneumonia Ureaplasma urealyticum 4
Bacillus spp. 4
Mixed Gram-positive ⁄negative flora 4
Klebsiella spp. 3
Staphylococcus aureus 2
Haemophilus influenzae 1
Enterobacter cloacae 1
Escherichia coli 1
Candida albicans 1
No organism isolated ⁄no
significant pathogens
9
Total 30
Table 2. Mannose-binding lectin (MBL) genotypes in rela-
tion to the occurrence of infection
MBL
genotype
Infection
Pneumonia BSI
BSI or pneumonia
or both
Yes No Yes No Yes No
Low MBL genotypes (%)
O ⁄O 4 (13.3) 10 (6.4) 3 (7.3) 1 (7.6) 6 (9.5) 8 (6.5)
XA ⁄O 0 15 (9.6) 4 (9.8) 11 (7.6) 4 (6.4) 1 (8.9)
XA ⁄XA 0 9 (5.8) 1 (2.4) 8 (5.5) 2 (3.2) 7 (5.7)
Total 4 (13.3) 34 (21.8) 8 (19.5) 30 (20.7) 12 (19.0) 26 (21.1)
Medium MBL genotypes (%)
YA ⁄O 6 (20.0) 26 (16.7) 5 (12.2) 27 (18.6) 10 (12.2) 22 (17.9)
YA ⁄XA 10 (33.3) 33 (21.2) 10 (24.4) 33 (22.8) 16 (25.4) 27 (22.0)
Total 16 (53.3) 59 (37.8) 15 (36.6) 60 (41.4) 26 (41.3) 49 (39.8)
High MBL genotype (%)
YA ⁄YA 10 (33.3) 63 (40.4) 18 (43.9) 55 (37.9) 25 (39.7) 48 (39.0)
Total (n = 186) 30 (100) 156 (100) 41 (100) 145 (100) 63 (100) 123 (100)
BSI, bloodstream infection.
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increases with the duration of gestation [23,24].
MBL is also detectable in cord blood [25], but it is
thought that there is no passive transfer of
maternal MBL to the foetus [26]. MBL levels
increase during the first 3 months of life in
response to environmental changes [27,28], and
recurrent infection has been described in MBL-
deficient infants [29].
An association was found in the present study
between the prevalence of low-MBL-producing
genotypes and pre-term birth, but no relationship
was revealed between low-MBL-producing geno-
types and the risk of nosomial infection. It is
known that pre-term neonates have lower MBL
concentrations than term neonates [30,31], and
that the adaptive immune system in this patient
category functions sub-optimally, perhaps be-
cause of lowered production of granulocyte col-
ony-stimulating factor, leading to a low number
of neutrophils [32]. The phagocytic function of
those neutrophils is also impaired [11,12,15], as is
opsonisation by IgG [33] and chemotaxis [13].
In contrast to the present findings in pre-term
neonates, MBL deficiency has been described as a
risk-factor for increased susceptibility to infection
in adults and older children, especially when
combined with another immunocompromising
factor, e.g., chemotherapy or haematological
malignancy [2,3,6,22,34–36]. MBL-variant alleles
have also been found to be a risk-factor for acute
respiratory illness in children aged 6–17 months,
which is an age at which the protecting mater-
nally-acquired IgG antibodies have disappeared
and the adaptive immune system is still immature
[3]. Therefore, the lack of a correlation in the
present patient population was unexpected. How-
ever, Ahrens et al. [37] also failed to find a
relationship between mutations in the MBL gene
and sepsis in premature neonates, but reported a
clear correlation with gestational age. Unfortu-
nately, no information concerning causative
microorganisms for infection related to MBL
genotype was provided.
There are several hypotheses to explain the
absence of any relationship between the risk of
infection and the MBL genotype in pre-term
infants requiring intensive care treatment, despite
their premature adaptive immune systems. First,
there was a high prevalence of BSIs caused by
CoNS in this patient group. It is known that MBL
binds poorly to CoNS [38], and it is therefore
likely that complement activation through MBL
binding is not effective in infections caused by
these microorganisms, so that MBL is not protec-
tive. Because the number of patients with infec-
tions caused by microorganisms other than CoNS
was low in the present study, a possible protec-
tive effect of MBL in such infections might not be
detectable. The meaning of a single blood culture
positive for CoNS is debatable, but because of the
small circulating volume in pre-term neonates, it
is not common practice to obtain additional blood
cultures for sepsis investigations. CDC-approved
definitions were used for microbiologically con-
firmed BSI, which include the isolation of a
bacterium belonging to the normal skin flora in
the presence of a central venous catheter, which
was always the case in the present study [18].
Second, the MBL genotype may not be a good
predictor of MBL function in individual patients
Table 3. Multivariate analysis of the mannose-binding lectin (MBL) genotype in relation to the risk of infectiona
n
BSI OR (95% CI) Pneumonia OR (95% CI)
BSI or pneumonia or both OR
(95% CI)
n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI)
Promotor exon genotype [21]
YA ⁄YA 72 18 (25) Reference group 10 (14) Reference group 25 (35) Reference group
YA ⁄XA 44 10 (23) 0.59 (0.22–1.61) 10 (23) 1.54 (0.56–4.22) 16 (36) 0.71 (0.28–1.77)
XA ⁄XA 9 1 (11) 0.45 (0.04–4.93) 0 NA 2 (22) 0.24 (0.02–2.59)
YA ⁄O 32 5 (16) 0.46 (0.14–1.53) 6 (19) 1.42 (0.45–4.51) 10 (31) 0.72 (0.26–2.02)
XA ⁄O 15 4 (27) 1.64 (0.39–6.94) 0 NA 4 (27) 0.87 (0.21–3.58)
O ⁄O 14 3 (21) 0.53 (0.11–2.46) 4 (29) 2.16 (0.53–8.81) 6 (43) 1.01 (0.26–3.95)
Total 186 41 (22) 30 (16) 63 (34)
Birth-weight category 3.65 (2.25–5.92) 2.16 (1.36–3.45) 3.73 (2.40–5.75)
Exon genotype [22]
A ⁄A 125 29 (23) Reference group 20 (16) Reference group 43 (34) Reference group
A ⁄O 47 9 (19) 0.89 (0.35–2.23) 6 (13) 0.85 (0.31–2.34) 14 (30) 0.94 (0.41–2.14)
O ⁄O 14 3 (21) 0.68 (0.16–2.97) 4 (29) 1.92 (0.51–7.23) 6 (43) 1.24 (0.34–4.57)
Total 186 41 (22) 30 63 (34)
Birth-weight category 3.42 (2.15–5.46) 2.26 (1.43–3.57) 3.66 (2.39–5.65)
BSI, bloodstream infection; NA, not applicable.
aFor estimation of the infection risk, the wild-type genotype was used as the reference group.
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because of significant individual variability in the
correlation between genotype and MBL function
[6]. Even normal MBL levels can be associated
with a non-functional MBL system because of,
e.g., a deficiency in MBL-associated serine prote-
ase 2 [39]. Furthermore, individuals with an
identical genotype may differ in MBL serum
levels by up to ten-fold [40].
Functional MBL pathway assays have now
been developed, and these have led to a better
understanding of the relationship between geno-
type and levels of functional MBL. It appears that,
especially with heterozygosity, the amount of
MBL in the circulation is less dependent on the
genotype than was predicted previously [41,42].
Only high molecular size MBL activates the
complement system efficiently. The MBL function
in heterozygous individuals may therefore be
highly dependent on the promoter function of the
wild-type allele [42].
The present study inferred abnormalities in the
MBL levels, based on the different haplotypes that
were determined by SNP analysis. The nested
PCR approach used with DNA recovered from
Guthriecards was very efficient, and the tech-
nique enabled MBL alleles to be determined for
neonates after they had been discharged from
hospital, without a need to obtain new blood
specimens. One neonate had a combination of
SNPs that did not belong to the six well-known
haplotypes investigated in the present study, but
additional MBL haplotypes have been described
recently [43]. Overall, it was concluded that the
six MBL haplotypes investigated did not correlate
with the risk of infection in pre-term neonates in
an NICU in which the majority of infections were
caused by CoNS.
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